BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30660643)

  • 1. Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.
    Ferrua F; Galimberti S; Courteille V; Slatter MA; Booth C; Moshous D; Neven B; Blanche S; Cavazzana M; Laberko A; Shcherbina A; Balashov D; Soncini E; Porta F; Al-Mousa H; Al-Saud B; Al-Dhekri H; Arnaout R; Formankova R; Bertrand Y; Lange A; Smart J; Wolska-Kusnierz B; Aquino VM; Dvorak CC; Fasth A; Fouyssac F; Heilmann C; Hoenig M; Schuetz C; Kelečić J; Bredius RGM; Lankester AC; Lindemans CA; Suarez F; Sullivan KE; Albert MH; Kałwak K; Barlogis V; Bhatia M; Bordon V; Czogala W; Alonso L; Dogu F; Gozdzik J; Ikinciogullari A; Kriván G; Ljungman P; Meyts I; Mustillo P; Smith AR; Speckmann C; Sundin M; Keogh SJ; Shaw PJ; Boelens JJ; Schulz AS; Sedlacek P; Veys P; Mahlaoui N; Janda A; Davies EG; Fischer A; Cowan MJ; Gennery AR;
    J Allergy Clin Immunol; 2019 Jun; 143(6):2238-2253. PubMed ID: 30660643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
    Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
    Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan.
    Mitsui-Sekinaka K; Imai K; Sato H; Tomizawa D; Kajiwara M; Nagasawa M; Morio T; Nonoyama S
    J Allergy Clin Immunol; 2015 Oct; 136(4):1018-24. PubMed ID: 25840720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation in CD40 ligand deficiency: A single-center experience.
    Uygun DFK; Uygun V; Karasu GT; Daloğlu H; Öztürkmen SI; Çelmeli F; Törün SH; Özen A; Barış S; Aydıner EK; Yalçın K; Kılıç SÇ; Hazar V; Bingöl A; Yeşilipek A
    Pediatr Transplant; 2020 Sep; 24(6):e13768. PubMed ID: 32573870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience.
    Tomizawa D; Imai K; Ito S; Kajiwara M; Minegishi Y; Nagasawa M; Morio T; Nonoyama S; Mizutani S
    Am J Hematol; 2004 May; 76(1):33-9. PubMed ID: 15114594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis.
    Quarello P; Tandoi F; Carraro F; Vassallo E; Pinon M; Romagnoli R; David E; Dell Olio D; Salizzoni M; Fagioli F; Calvo PL
    Transplantation; 2018 May; 102(5):823-828. PubMed ID: 29377874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002.
    Gennery AR; Khawaja K; Veys P; Bredius RG; Notarangelo LD; Mazzolari E; Fischer A; Landais P; Cavazzana-Calvo M; Friedrich W; Fasth A; Wulffraat NM; Matthes-Martin S; Bensoussan D; Bordigoni P; Lange A; Pagliuca A; Andolina M; Cant AJ; Davies EG
    Blood; 2004 Feb; 103(3):1152-7. PubMed ID: 14525761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review].
    Wang P; Qian XW; Wang HS; Jiang WJ; Sun JQ; Wang XC; Zhai XW
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):830-835. PubMed ID: 34587678
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy.
    Jacobsohn DA; Emerick KM; Scholl P; Melin-Aldana H; O'Gorman M; Duerst R; Kletzel M
    Pediatrics; 2004 Feb; 113(2):e122-7. PubMed ID: 14754981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Immune Deficiency Treatment Consortium (PIDTC) report.
    Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Pai SY; Ballard B; Bauer SC; Bleesing JJ; Boyle M; Brower A; Buckley RH; van der Burg M; Burroughs LM; Candotti F; Cant AJ; Chatila T; Cunningham-Rundles C; Dinauer MC; Dvorak CC; Filipovich AH; Fleisher TA; Bobby Gaspar H; Gungor T; Haddad E; Hovermale E; Huang F; Hurley A; Hurley M; Iyengar S; Kang EM; Logan BR; Long-Boyle JR; Malech HL; McGhee SA; Modell F; Modell V; Ochs HD; O'Reilly RJ; Parkman R; Rawlings DJ; Routes JM; Shearer WT; Small TN; Smith H; Sullivan KE; Szabolcs P; Thrasher A; Torgerson TR; Veys P; Weinberg K; Zuniga-Pflucker JC;
    J Allergy Clin Immunol; 2014 Feb; 133(2):335-47. PubMed ID: 24139498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.
    Choi YB; Lee JW; Sung KW; Koo HH; Kim HJ; Yoo KH
    J Korean Med Sci; 2019 Feb; 34(6):e46. PubMed ID: 30787679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.
    Lankester AC; Neven B; Mahlaoui N; von Asmuth EGJ; Courteille V; Alligon M; Albert MH; Serra IB; Bader P; Balashov D; Beier R; Bertrand Y; Blanche S; Bordon V; Bredius RG; Cant A; Cavazzana M; Diaz-de-Heredia C; Dogu F; Ehlert K; Entz-Werle N; Fasth A; Ferrua F; Ferster A; Formankova R; Friedrich W; Gonzalez-Vicent M; Gozdzik J; Güngör T; Hoenig M; Ikinciogullari A; Kalwak K; Kansoy S; Kupesiz A; Lanfranchi A; Lindemans CA; Meisel R; Michel G; Miranda NAA; Moraleda J; Moshous D; Pichler H; Rao K; Sedlacek P; Slatter M; Soncini E; Speckmann C; Sundin M; Toren A; Vettenranta K; Worth A; Yeşilipek MA; Zecca M; Porta F; Schulz A; Veys P; Fischer A; Gennery AR
    J Allergy Clin Immunol; 2022 May; 149(5):1744-1754.e8. PubMed ID: 34718043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
    França TT; Barreiros LA; Al-Ramadi BK; Ochs HD; Cabral-Marques O; Condino-Neto A
    Expert Rev Clin Immunol; 2019 May; 15(5):529-540. PubMed ID: 30681380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
    Albert MH; Sirait T; Eikema DJ; Bakunina K; Wehr C; Suarez F; Fox ML; Mahlaoui N; Gennery AR; Lankester AC; Beier R; Bernardo ME; Bigley V; Lindemans CA; Burns SO; Carpenter B; Dybko J; Güngör T; Hauck F; Lum SH; Balashov D; Meisel R; Moshous D; Schulz A; Speckmann C; Slatter MA; Strahm B; Uckan-Cetinkaya D; Meyts I; Vallée TC; Wynn R; Neven B; Morris EC; Aiuti A; Maschan A; Aljurf M; Gedde-Dahl T; Gurman G; Bordon V; Kriván G; Locatelli F; Porta F; Valcárcel D; Beguin Y; Faraci M; Kröger N; Kulagin A; Shaw PJ; Veelken JH; Diaz de Heredia C; Fagioli F; Felber M; Gruhn B; Holter W; Rössig C; Sedlacek P; Apperley J; Ayas M; Bodova I; Choi G; Cornelissen JJ; Sirvent A; Khan A; Kupesiz A; Lenhoff S; Ozdogu H; von der Weid N; Rovira M; Schots R; Vinh DC
    Blood; 2022 Oct; 140(14):1635-1649. PubMed ID: 35344580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT.
    Neven B; Ferrua F
    Front Pediatr; 2019; 7():552. PubMed ID: 32039114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplant for hyper-IgM syndrome due to CD40L defects: A single-center experience.
    Al-Saud B; Al-Mousa H; Al-Ahmari A; Al-Ghonaium A; Ayas M; Alhissi S; Al-Muhsen S; Al-Seraihy A; Arnaout R; Al-Dhekri H; Hawwari A
    Pediatr Transplant; 2015 Sep; 19(6):634-9. PubMed ID: 26073206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD).
    Dinardo L; Brown V; Perez E; Bunin N; Sullivan KE
    Pediatr Transplant; 2012 Feb; 16(1):63-72. PubMed ID: 22093026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
    Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG; Chu JI; Ciocarlie OC; Doğu F; Gaspar HB; Geha RS; Gennery AR; Hauck F; Hawwari A; Hickstein DD; Hoenig M; Ikinciogullari A; Klein C; Kumar A; Ifversen MRS; Matthes S; Metin A; Neven B; Pai SY; Parikh SH; Picard C; Renner ED; Sanal Ö; Schulz AS; Schuster F; Shah NN; Shereck EB; Slatter MA; Su HC; van Montfrans J; Woessmann W; Ziegler JB; Albert MH;
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):848-855. PubMed ID: 30391550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.